About Aalborg Universitetshospital, Syd
Aalborg Universitetshospital er det største hospital/sygehus i Nordjylland. Aalborg Universitetshospital omfatter matriklerne Syd og Nord i Aalborg, matriklerne Farsø, Hobro og Thisted - samt en række satellitmatrikler i Aalborg på Havrevangen, Vesterbro, Kastetvej, Fåborgvej og Nybrovej.
Clinical Trials at Aalborg Universitetshospital, Syd
During the past decade, Aalborg Universitetshospital, Syd conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Aalborg Universitetshospital, Syd"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Aalborg Universitetshospital, Syd
According to Clinical.Site data, the most researched conditions in "Aalborg Universitetshospital, Syd" are
"Advanced Malignancies" (1 trials), "Metastatic Colorectal Cancer" (1 trials), "NSCLC" (1 trials), "Neoplasms" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Aalborg Universitetshospital, Syd" in a lesser frequency.
Clinical Trials Intervention Types at Aalborg Universitetshospital, Syd
Most popular intervention types in "Aalborg Universitetshospital, Syd" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetuximab" (2 trials), "Encorafenib" (2 trials), "5-FU" (1 trials), "Avelumab" (1 trials) and "Axitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Aalborg Universitetshospital, Syd
The vast majority of trials in "Aalborg Universitetshospital, Syd" are
4 trials for "All" genders.
Clinical Trials Status at Aalborg Universitetshospital, Syd
Currently, there are NaN active trials in "Aalborg Universitetshospital, Syd".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Aalborg Universitetshospital, Syd,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Aalborg Universitetshospital, Syd, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".